PCI San Diego, Inc.

Form 483 issued September 20, 2023 · San Diego, California

Observations
3
Pages
3
FEI number
3004575449

In short: On September 20, 2023, FDA issued a Form 483 with 3 observations to PCI San Diego, Inc. in San Diego, California (FEI 3004575449). The investigator was Cassandra L. Abellard. Most observations concern production and quality system; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

2 of 3 observations on this 483 concern production.

Production2
Quality system1

Most cited: 21 CFR 211.113 (2×) · 211.198 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Your firm's microbial cross-contamination control in the(b) (4) vial filling machine and the (b) (4) filling…

  2. 02

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are…

  3. 03

    Complaint records are deficient in that they do not include the findings of…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at PCI San Diego, Inc.?

FDA listed 3 observations on this Form 483, mostly about production and quality system. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected PCI San Diego, Inc.?

Cassandra L. Abellard is named on this Form 483. Each investigator has a profile showing what they cite most.

When was PCI San Diego, Inc. inspected by FDA?

This Form 483 is dated September 20, 2023.

How do I get the full Form 483 for PCI San Diego, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free